Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-08
2011-03-08
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S266200, C548S267200
Reexamination Certificate
active
07902240
ABSTRACT:
Disclosed are new substituted pyrazole and triazole compounds of Formula (I) and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses thereof:
REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4837028 (1989-06-01), Allen
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5023252 (1991-06-01), Hseih et al.
patent: 5185450 (1993-02-01), Owen
patent: 6545004 (2003-04-01), Finer et al.
patent: 6562831 (2003-05-01), Finer et al.
patent: 6630479 (2003-10-01), Finer et al.
patent: 2005/0228002 (2005-10-01), Wang et al.
patent: 2005/0261337 (2005-11-01), Wang et al.
patent: 2006/0084687 (2006-04-01), Boyce et al.
patent: 2007/0037853 (2007-02-01), Barsanti et al.
patent: 2007/0270473 (2007-11-01), Saunders et al.
patent: WO 00/59887 (2000-10-01), None
patent: WO 01/30768 (2001-05-01), None
patent: WO 02/28839 (2002-04-01), None
patent: WO 02/056880 (2002-07-01), None
patent: WO 02/057244 (2002-07-01), None
patent: WO 03/039460 (2003-05-01), None
patent: WO 03/043995 (2003-05-01), None
patent: WO 03/049527 (2003-06-01), None
patent: WO 03/049678 (2003-06-01), None
patent: WO 03/049679 (2003-06-01), None
patent: WO 03/050064 (2003-06-01), None
patent: WO 03/050122 (2003-06-01), None
patent: WO 03/059289 (2003-07-01), None
patent: WO 03/070701 (2003-08-01), None
patent: WO 03/079973 (2003-10-01), None
patent: WO 03/094839 (2003-11-01), None
patent: WO 03/097053 (2003-11-01), None
patent: WO 03/099211 (2003-12-01), None
patent: WO 03/103575 (2003-12-01), None
patent: WO 03/105855 (2003-12-01), None
patent: WO 03/106417 (2003-12-01), None
patent: WO 2004/004652 (2004-01-01), None
patent: WO 2004/006865 (2004-01-01), None
patent: WO 2004/009036 (2004-01-01), None
patent: WO 2004/018058 (2004-03-01), None
patent: WO 2004/024086 (2004-03-01), None
patent: WO 2004/026226 (2004-04-01), None
patent: WO 2004/100873 (2004-11-01), None
patent: WO 2004/103282 (2004-12-01), None
patent: WO 2006/002236 (2006-01-01), None
U.S. Appl. No. 11/969,164, filed Jan. 3, 2008, Boyce et al.
Blangy, A. et al., “Phosphorylation by p34cdc2Regulates Spindle Assoication of Human Eg5, a Kinesin-Related Motor Essential for Bipolar Spindle Formation In Vivo”,Cell83:1159-1169, 1995.
Coleman, P.J. et al., “Inhibitors of the Mitotic Kinesin Spindle Protein”. Expert Opinion on Therapeutic Patents, Ashely Publications, 14(12):1659-1668, 2004.
Debonis, S., et al., “Interaction of the Mitotic Inhibitor Monastrol With Human Kinesin EG5”.Biochemistry, 2003, 42:338-349.
Enos, A.P. et al. “Mutation of a Gene That Encodes a Kinesin-like Protein Blocks Nuclear Division in A. nidulans”.Cell60:1019-1027, 1990.
Giet, R., et al., “TheXenopus laevis Aurora-related Protein kinase pEg2 Associates with and Phosphorylates the Kinesin-related Protein XIEg5”.J. Biol. Chem. 274(21):15005-15013, 1999.
Hagan, I. et al., “Novel Potential Mitotic Motor Protein Encoded by the Fission YeastCut7+ Gene”.Nature347:563-566, 1990.
Kaiser, A., et al., “All-trans-Retinoic Acid-mediated Growth Inhibition Involves Inhibition of Human Kenesin-related Protein HsEg5”.J. Biol. Chem. 274(27):18925-18931, 1999.
Kapoor, T.M., et al., “Probing Spindle Assembly Mechanisms with Monastrol, a Small Molecule Inhibitor of the Mitotic Kinesin, Eg5”.J. Cell Biol., 150(5):975-988, 2000.
Mayer, T.U., et al., “Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen”.Science 286:971-974, 1999.
Barsanti Paul A.
Duhl David
Mendenhall Kris
Renhowe Paul A.
Walter Annette O.
Kathardekar Vinit
Novartis AG
Shiao Rei-tsang
LandOfFree
Substituted pyrazole and triazole compounds as KSP inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrazole and triazole compounds as KSP inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazole and triazole compounds as KSP inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2725744